Healthcare Triangle, Inc.
For the period ended Jun 30, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 13, 2026
HCTI$4.21-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Statements of Cash Flows
| Six Months Ended June 30, | ||||
|---|---|---|---|---|
| Note · 2026 · 2025 | ||||
| (In ‘000) | ||||
| Cash flows from operating activities | ||||
| Net loss | $(10,615) | $(3,068) | ||
| Adjustment to reconcile net loss to net cash provided by / (used in) operating activities | ||||
| Depreciation and amortization | 1,339 | 12 | ||
| Net unrealised exchange loss | 80 | - | ||
| Change in fair value | 3,088 | - | ||
| Common stock issued for services | - | 88 | ||
| Amortization of debt discount | - | 223 | ||
| Other income | - | (124) | ||
| Stock compensation expenses | - | 36 | ||
| Interest expenses | 173 | - | ||
| Interest expenses settled by equity | - | 316 | ||
| Interest expense on right-of-use liability | 426 | - | ||
| Bad debt expense | 3 | 142 | - | |
| Gain on sale of furniture and equipment | (6) | - | ||
| Provision for advances | 4 | 626 | - | |
| Tax expense | 24 | - | ||
| Changes in working capital: | ||||
| Accounts receivable | 606 | (752) | ||
| Other current assets | (358) | (133) | ||
| Advances | (60) | - | ||
| Due from affiliates | - | (2,823) | ||
| Accounts payable | (2,387) | (1,375) | ||
| Other current liabilities | (775) | (592) | ||
| Net cash used in operating activities | (7,697) | (8,192) | ||
| Cash flows from investing activities | ||||
| Purchase of furniture and equipment | (50) | (3) | ||
| Disposal of furniture and equipment | 6 | |||
| Purchase of intangible assets | (3) | - | ||
| Acquisition of Teyame, net off cash acquired on business combination | 6 | (9,197) | - | |
| Acquisition of assets | - | (600) | ||
| Net cash used in investing activities | (9,244) | (603) | ||
| Cash flows from financing activities | ||||
| Proceeds from debt | 9 | 76,594 | - | |
| Repayment of debt | 9 | (74,269) | (1,674) | |
| Payment of lease liability | 8 | (381) | - | |
| Proceeds from equity issuance | 9,418 | 13,677 | ||
| Interest paid | (170) | - | ||
| Net cash provided by financing activities | 11,192 | 12,003 | ||
| Effect of exchange rate changes on cash and cash equivalents | 30 | - | ||
| Net (decrease)/increase in cash and cash equivalents | (5,719) | 3,208 | ||
| Cash and cash equivalents | ||||
| Cash and cash equivalents at the beginning of the year | 7,625 | 20 | ||
| Cash and cash equivalents at the end of the period | $1,906 | $3,228 | ||
| Supplementary disclosure of cash flows information | ||||
| Interest | $ | - | $435 | |
| Cashless warrants issued | - | 14,710 | ||
| Deferred offering cost | 112 | - | ||
| Conversion of debt to common stock | 10,167 | 1,191 | ||
| Acquisition of Teyame (see note 6[B] for details) | 37,800 | - | ||
| Operating right-of-use asset | 1,193 | - | ||
| Acquisition of assets | $ | - | $5,100 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.